CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer

Published:2016-02-15 Issue:36 Volume:35 Page:4762-4772
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Wright H J,Arulmoli J,Motazedi M,Nelson L J,Heinemann F S,Flanagan L A,Razorenova O V

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc20167.pdf

Reference54 articles.

1. Metzger-Filho O, Tutt A, de Azambuja E, Saini KS, Viale G, Loi S et al. Dissecting the heterogeneity of triple-negative breast cancer. J Clin Oncol 2012; 30: 1879–1887.

2. Law ME, Corsino PE, Jahn SC, Davis BJ, Chen S, Patel B et al. Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms. Oncogene 2013; 32: 1316–1329.

3. Casar B, Rimann I, Kato H, Shattil SJ, Quigley JP, Deryugina EI . In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling. Oncogene 2014; 33: 255–268.

4. Uekita T, Jia L, Narisawa-Saito M, Yokota J, Kiyono T, Sakai R . CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma. Mol Cell Biol 2007; 27: 7649–7660.

5. Uekita T, Tanaka M, Takigahira M, Miyazawa Y, Nakanishi Y, Kanai Y et al. CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma. Am J Pathol 2008; 172: 1729–1739.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis;Cancer Biology & Medicine;2024-07-01

2. Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis;Journal of Biological Chemistry;2024-06

3. Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese;Cell Reports Medicine;2023-11

4. Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment;Molecular Oncology;2023-04-20

5. Detection and Isolation of Circulating Tumor Cells from Breast Cancer Patients Using CUB Domain-Containing Protein 1;Journal of Proteome Research;2023-03-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3